Terminal is the live negotiation environment. Terminal access is restricted to approved users, to request access or you are having trouble logging in, contact email@example.com.
April 12, 2021
Boston, MA, USA
PharmaCCX announces today that Richard Bergström is leaving the company. Richard is one of the co-founders of the company and his role at the company has been leading Customer Development including lobbying and sales to pharma, payers, and governments.
Since June 2020, in addition to his significant responsibilities at PharmaCCX, in his personal capacity he has taken on roles as Vaccine Coordinator for Sweden and subsequently as a negotiator for the European Commission. As he has become increasingly involved in this critical vaccine work he has not been able to contribute as actively to the company.
It is therefore in everyone’s best interest for him to move on so that he can focus more fully on this important work. The PharmaCCX team is grateful to have worked with Richard and wish him the best in this next stage of his career.